{
    "organizations": [],
    "uuid": "3f611c1b60f66ea2000b2355d1bd6b3f05ad25f0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-quidel-receives-510-clearance-for/brief-quidel-receives-510-clearance-for-quickvue-influenza-ab-test-idUSASB0C5KQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Quidel Receives 510(K) Clearance For Quickvue Influenza A+B Test",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Quidel Corp:\n* QUIDEL RECEIVES 510(K) CLEARANCE FOR QUICKVUE INFLUENZA A+B TEST, ASSAY MEETS FDA‘S CLASS II RIDT REQUIREMENTS\n* QUIDEL- ‍IN RECENT CLINICAL STUDY, CO‘S QUICKVUE INFLUENZA A+B TEST SHOWN TO MEET FDA RECLASSIFICATION CRITERIA FOR CLASS II RAPID INFLUENZA DIAGNOSTIC TESTS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T01:52:00.000+02:00",
    "crawled": "2018-02-14T02:13:14.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "quidel",
        "corp",
        "quidel",
        "receives",
        "k",
        "clearance",
        "quickvue",
        "influenza",
        "test",
        "assay",
        "meet",
        "fda",
        "class",
        "ii",
        "ridt",
        "requirement",
        "recent",
        "clinical",
        "study",
        "co",
        "quickvue",
        "influenza",
        "test",
        "shown",
        "meet",
        "fda",
        "reclassification",
        "criterion",
        "class",
        "ii",
        "rapid",
        "influenza",
        "diagnostic",
        "test",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}